Xu A - Search Results

1

Serum fibroblast growth factor 21 is associated with adverse lipid profiles and gamma-glutamyltransferase but not insulin sensitivity in Chinese subjects.

Li H, Bao Y, Xu A, Pan X, Lu J, Wu H, Lu H, Xiang K, Jia W. Li H, et al. Among authors: xu a. J Clin Endocrinol Metab. 2009 Jun;94(6):2151-6. doi: 10.1210/jc.2008-2331. Epub 2009 Mar 24. J Clin Endocrinol Metab. 2009. PMID: 19318452

2

Serum zinc-alpha2-glycoprotein correlates with adiposity, triglycerides, and the key components of the metabolic syndrome in Chinese subjects.

Yeung DC, Lam KS, Wang Y, Tso AW, Xu A. Yeung DC, et al. Among authors: xu a. J Clin Endocrinol Metab. 2009 Jul;94(7):2531-6. doi: 10.1210/jc.2009-0058. Epub 2009 Apr 7. J Clin Endocrinol Metab. 2009. PMID: 19351730

3

Fibroblast growth factor 21 levels are increased in nonalcoholic fatty liver disease patients and are correlated with hepatic triglyceride.

Li H, Fang Q, Gao F, Fan J, Zhou J, Wang X, Zhang H, Pan X, Bao Y, Xiang K, Xu A, Jia W. Li H, et al. Among authors: xu a. J Hepatol. 2010 Nov;53(5):934-40. doi: 10.1016/j.jhep.2010.05.018. Epub 2010 Jul 17. J Hepatol. 2010. PMID: 20675007

4

Circadian rhythm of circulating fibroblast growth factor 21 is related to diurnal changes in fatty acids in humans.

Yu H, Xia F, Lam KS, Wang Y, Bao Y, Zhang J, Gu Y, Zhou P, Lu J, Jia W, Xu A. Yu H, et al. Among authors: xu a. Clin Chem. 2011 May;57(5):691-700. doi: 10.1373/clinchem.2010.155184. Epub 2011 Feb 15. Clin Chem. 2011. PMID: 21325103

5

Distinct changes in serum fibroblast growth factor 21 levels in different subtypes of diabetes.

Xiao Y, Xu A, Law LS, Chen C, Li H, Li X, Yang L, Liu S, Zhou Z, Lam KS. Xiao Y, et al. Among authors: xu a. J Clin Endocrinol Metab. 2012 Jan;97(1):E54-8. doi: 10.1210/jc.2011-1930. Epub 2011 Oct 19. J Clin Endocrinol Metab. 2012. PMID: 22013098

6

Sodium butyrate stimulates expression of fibroblast growth factor 21 in liver by inhibition of histone deacetylase 3.

Li H, Gao Z, Zhang J, Ye X, Xu A, Ye J, Jia W. Li H, et al. Among authors: xu a. Diabetes. 2012 Apr;61(4):797-806. doi: 10.2337/db11-0846. Epub 2012 Feb 14. Diabetes. 2012. PMID: 22338096 Free PMC article.

7

Circulating adipocyte fatty acid-binding protein levels are independently associated with heart failure.

Liu M, Zhou M, Bao Y, Xu Z, Li H, Zhang H, Zhu W, Zhang J, Xu A, Wei M, Jia W. Liu M, et al. Among authors: xu a, xu z. Clin Sci (Lond). 2013 Jan;124(2):115-22. doi: 10.1042/CS20120004. Clin Sci (Lond). 2013. PMID: 23013043

8

Fibroblast growth factor 21 as an emerging metabolic regulator: clinical perspectives.

Woo YC, Xu A, Wang Y, Lam KS. Woo YC, et al. Among authors: xu a. Clin Endocrinol (Oxf). 2013 Apr;78(4):489-96. doi: 10.1111/cen.12095. Clin Endocrinol (Oxf). 2013. PMID: 23134073 Review.

9

High serum level of fibroblast growth factor 21 is an independent predictor of non-alcoholic fatty liver disease: a 3-year prospective study in China.

Li H, Dong K, Fang Q, Hou X, Zhou M, Bao Y, Xiang K, Xu A, Jia W. Li H, et al. Among authors: xu a. J Hepatol. 2013 Mar;58(3):557-63. doi: 10.1016/j.jhep.2012.10.029. Epub 2012 Nov 7. J Hepatol. 2013. PMID: 23142063

10

Long-term fenofibrate therapy increases fibroblast growth factor 21 and retinol-binding protein 4 in subjects with type 2 diabetes.

Ong KL, Rye KA, O'Connell R, Jenkins AJ, Brown C, Xu A, Sullivan DR, Barter PJ, Keech AC; FIELD study investigators. Ong KL, et al. Among authors: xu a. J Clin Endocrinol Metab. 2012 Dec;97(12):4701-8. doi: 10.1210/jc.2012-2267. Epub 2012 Nov 8. J Clin Endocrinol Metab. 2012. PMID: 23144467 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,865 results

Search Page

Filters